Prognosis

CureVac, U.K. Government Agree to Develop Future Covid Shots

CureVac to supply 50 million doses of any successful vaccine
Drugmaker, U.K. to assess mutated coronavirus strains

CureVac will work with the U.K.’s vaccines taskforce in assessing mutated strains that emerge. — CureVac will work with the U.K.’s vaccines taskforce in assessing mutated strains that emerge.
Photographer: Patrick Hipp/CureVac

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Tim Loh

February 5, 2021 at 12:35 PM UTC

Updated on

February 5, 2021 at 4:53 PM UTC

This article is for subscribers only.

CureVac NV will collaborate with the U.K. to develop vaccine candidates against coronavirus variants, with the government securing 50 million doses of any successful shot.

The German biotech will work with the U.K.’s vaccine task force in assessing mutated strains that emerge, and clinical studies in the U.K. may be expedited for faster regulatory clearance, according to a statement Friday. The move extends the country’s investment in Covid-19 prevention as Britain races ahead of the European Union in vaccinations.